Fundz

Deciphera Pharmaceuticals, Llc reported raising $52.3 Million in an initial SEC Form D filing, from an offering of $52.3 Million

PRIVATEJun 05, 2017

Amount Raised

$52.3 Million

$52.3 Million sold, per SEC Form D (first sale Jun 5, 2017)

Round Type

Venture

WalthamBiotechnologyHealthcareHealth CareTherapeutics

Quick answer

Deciphera Pharmaceuticals raised $52.3 Million in a funding round, dated June 5, 2017. Deciphera Pharmaceuticals is based in Waltham, Massachusetts, United States.

How much did Deciphera Pharmaceuticals raise?
Deciphera Pharmaceuticals raised $52.3 Million in a funding round on June 5, 2017.
What does Deciphera Pharmaceuticals do?
Deciphera is a biopharmaceutical company focused on discovering, developing, and commercializing important new medicines to improve the lives of people with cancer.
Where is Deciphera Pharmaceuticals based and how big is it?
Deciphera Pharmaceuticals is based in Waltham, Massachusetts, United States.

Source: Fundz verified event record.

Who else raised in Healthcare and Therapeutics around the same time

Companies in the same sectors as Deciphera Pharmaceuticals that raised within 45 days of this round, from Fundz verified event records.

  • Vaccinex raised $6M on July 7, 2017.
  • CytoDyn raised $1.1M (Seed) on June 14, 2017.
  • ClearPoint Neuro raised $13M on June 6, 2017.
  • Cocrystal Pharma, Inc. raised $3M (Seed) on May 2, 2017.
  • Streamex Corp. raised $1.6M on July 20, 2017.
  • CEL-SCI Corporation raised an undisclosed amount on July 17, 2017.

Who to call at Deciphera Pharmaceuticals, and when

A new round usually means Deciphera Pharmaceuticals is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Deciphera Pharmaceuticals raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Deciphera Pharmaceuticals, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Deciphera Pharmaceuticals. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Deciphera Pharmaceuticals

Location

Waltham, Massachusetts, United States

About

Deciphera is a biopharmaceutical company focused on discovering, developing, and commercializing important new medicines to improve the lives of people with cancer. We are leveraging our proprietary switch-control kinase inhibitor platform and deep expertise in kinase biology to develop a broad portfolio of innovative medicines. In addition to advancing multiple product candidates from our platform in clinical studies, QINLOCK® is Deciphera’s switch-control inhibitor for the treatment of fourth-line GIST. QINLOCK is approved in Australia, Canada, China, the European Union, Hong Kong, Israel, Macau, New Zealand, Singapore, Switzerland, Taiwan, the United Kingdom, and the United States.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Deciphera Pharmaceuticals raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for Deciphera Pharmaceuticals's next move

See what Strategic adds

Deciphera Pharmaceuticals raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.